Envivo

Envivo Bio is a South San Francisco-based biotechnology company pioneering a new approach to understanding the human gut microbiome. The company has developed CapScan, an ingestible, non-invasive sampling device designed to collect longitudinal samples from the small intestine, an area previously difficult to access without invasive procedures. By moving beyond stool samples, Envivo's platform enables the study of the "dark matter" of the gut, including spatial variations in microbial populations, proteins, and metabolites. This high-resolution data is used to identify new biomarkers and therapeutic targets for a wide range of conditions, including inflammatory bowel disease and metabolic disorders. Envivo's technology aims to transform microbiome research from observational studies into a precise tool for drug development and clinical diagnostics.